Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, Yesterday
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.

TAVR comparable to SAVR in real-world intermediate-risk patients

Pearl Toh
28 Mar 2017
Dr Matthew Brennan
Transcatheter aortic valve replacement (TAVR) is an effective and safe alternative to surgical aortic valve replacement (SAVR) for intermediate- and high-risk patients in the real world, with no significant difference in stroke and mortality rates at 1 year, and discharge to home being more common among TAVR patients, according to the ADVICE* study presented at the recent ACC.17 Scientific Session held in Washington, DC, US.    

Although previous randomized clinical trials (RCTs) have shown TAVR to be safe and effective in intermediate- and high-risk patients with aortic stenosis, the real-world GARY** trial showed a higher 1-year mortality rate among intermediate-risk patients who received TAVR than SAVR. This raised questions regarding how generalizable are RCT results of TAVR to the real world and to different patient subgroups with different risk profiles, according to Dr Matthew Brennan of Duke University Medical Center in Durham, North Carolina, US.

The current real-world observational ADVICE study included 9,464 propensity-matched patients (median age 82 years, 48 percent female) at intermediate or high risk for surgery (STS PROM*** ≥3 percent) in the TVT# Registry and STS## Database who underwent TAVR or SAVR in the US. [ACC.17, abstract 408-08]

Compared with SAVR, TAVR patients were more commonly being discharged home (70 percent vs 41 percent; p<0.01), which according to Brennan, “reflects a less demanding early recovery [among TAVR patients].”

In-hospital mortality rate was lower (3 percent vs 5 percent; p<0.001) and postoperative length of stay in hospital was shorter (4 vs 8 days; p<0.001) among patients who received TAVR compared with SAVR. On the other hand, new pacemaker implantation (12.8 percent vs 6.3 percent; p<0.001) and in-hospital major vascular complication (4.2 percent vs 0.4 percent; p<0.001) were higher with TAVR, while in-hospital stroke incidence was similar between the TAVR and SAVR groups (2.5 percent vs 2.7 percent; p=0.4), which Brennan said were consistent with results from previous clinical trials.      

At 1 year postprocedure, rates of death (hazard ratio [HR], 0.93; p=0.18) and stroke (HR, 1.18; p=0.13) were similar between the two groups, with the data from subgroup analysis (including age, gender, previous cardiac surgery, prior stroke, and chronic lung disease) being consistent with the overall comparative findings for each clinical outcome.

Subanalyses indicate that patients with prior cardiac surgery or chronic lung disease might benefit more from TAVR than SAVR, observed Brennan.  

Both the TAVR and SAVR groups also had similar ‘days alive and out of hospital (DAOH)’, with the majority of patients in both groups spending <1 month in an acute care hospital within the first year after treatment. In addition, similar DAOH between the two groups was observed even when patients were stratified by STS PROM score (≥3 and <5, ≥3 and <8, ≥8).

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, Yesterday
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.